Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
COYA is expected to report earnings to fall 129.55% to 12 cents per share on August 12
Q2'25
Est.
$0.13
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.22
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.42
The last earnings report on May 13 showed earnings per share of -43 cents, beating the estimate of -46 cents. With 14.98K shares outstanding, the current market capitalization sits at 102.02M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. COYA showed earnings on May 13, 2025. You can read more about the earnings report here.